Department of Orthopaedic Surgery, University of South Florida, MDF 5th Floor, 13220 USF Laurel Drive, Tampa, FL 33612, USA.
J Bone Joint Surg Am. 2012 Mar 21;94(6):537-47. doi: 10.2106/JBJS.I.01575.
The optimal treatment of malignant pediatric lower-extremity bone tumors is controversial. Expandable endoprostheses allow limb preservation, but the revision rate and limited function are considered barriers to their use. This study investigated the functional, emotional, and oncologic outcomes of thirty-eight patients treated with an expandable endoprosthesis.
A retrospective chart review was performed, and surviving patients were asked to complete the Musculoskeletal Tumor Society (MSTS) outcomes instrument and the Pediatric Outcomes Data Collection Instrument (PODCI). Additional data including the range of hip and knee motion, limb-length discrepancy, and total lengthening were also obtained.
Thirty-eight patients were treated with an expandable endoprosthesis, and twenty-six of these patients were alive at the time of the study. The mean global MSTS score was 26.1, and the mean global PODCI score was 85.8. The mean emotional acceptance and happiness subscores were high. The mean sagittal-plane hip motion in patients who had undergone replacement of the proximal aspect of the femur was 103°. The mean knee motion in patients who had undergone replacement of the proximal aspect of the femur, the distal aspect of the femur, or the proximal aspect of the tibia was 127°, 97°, and 107°, respectively. The mean lengthening at the time of skeletal maturity was 4.5 cm, and the mean limb-length discrepancy was 0.7 cm. Forty-two percent of the patients experienced complications, with ten patients requiring prosthesis revision and two of these patients requiring amputation.
Current technology does not offer a single best reconstruction option for children. Previous studies and the present series have indicated that physical and emotional functioning in patients treated with an expandable endoprosthesis are good but that complication rates remain high. Amputation and rotationplasty are alternative treatments if patients and their families are amenable to these procedures. The literature supports no single superior treatment among these three options with regard to physical or emotional health.
恶性儿童下肢骨肿瘤的最佳治疗方法存在争议。可膨胀假体可保留肢体,但翻修率和功能有限被认为是其应用的障碍。本研究调查了 38 例接受可膨胀假体治疗的患者的功能、情感和肿瘤学结果。
对病历进行回顾性分析,并对存活患者进行肌肉骨骼肿瘤学会(MSTS)结果量表和儿科结局数据采集量表(PODCI)评估。还获得了髋关节和膝关节运动范围、肢体长度差异和总延长等额外数据。
38 例患者接受了可膨胀假体治疗,其中 26 例患者在研究时仍存活。全球 MSTS 平均评分为 26.1,全球 PODCI 平均评分为 85.8。情感接受和幸福感平均分较高。接受股骨近端置换的患者矢状面髋关节运动平均为 103°。接受股骨近端、股骨远端或胫骨近端置换的患者膝关节运动平均为 127°、97°和 107°。骨骼成熟时的平均延长长度为 4.5 厘米,平均肢体长度差异为 0.7 厘米。42%的患者发生并发症,10 例需要假体翻修,其中 2 例需要截肢。
目前的技术并不能为儿童提供单一的最佳重建选择。以前的研究和本系列研究表明,接受可膨胀假体治疗的患者在身体和情感功能方面表现良好,但并发症发生率仍然很高。如果患者及其家属能够接受这些手术,截肢和旋转成形术是替代治疗方法。文献支持这三种治疗方法在身体或情感健康方面没有一种具有绝对优势。